G266-1325 Screening compound: 2-(3,4-diethoxyphenyl)-N-[1,4-dimethyl-2,3-dioxo-7-(pyrrolidin-1-yl)-1,2,3,4-tetrahydroquinoxalin-6-yl]acetamide

G266-1325 Screening compound: 2-(3,4-diethoxyphenyl)-N-[1,4-dimethyl-2,3-dioxo-7-(pyrrolidin-1-yl)-1,2,3,4-tetrahydroquinoxalin-6-yl]acetamide
G266-1325 Screening compound: 2-(3,4-diethoxyphenyl)-N-[1,4-dimethyl-2,3-dioxo-7-(pyrrolidin-1-yl)-1,2,3,4-tetrahydroquinoxalin-6-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G266-1325
2-(3,4-diethoxyphenyl)-N-[1,4-dimethyl-2,3-dioxo-7-(pyrrolidin-1-yl)-1,2,3,4-tetrahydroquinoxalin-6-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G266-1325

Molecular Formula

C26H32N4O5 (C26 H32 N4 O5)

Compound Name

2-(3,4-diethoxyphenyl)-N-[1,4-dimethyl-2,3-dioxo-7-(pyrrolidin-1-yl)-1,2,3,4-tetrahydroquinoxalin-6-yl]acetamide

IUPAC name

2-(34-diethoxyphenyl)-N-[14-dimethyl-23-dioxo-7-(pyrrolidin-1-yl)-1234-tetrahydroquinoxalin-6-yl]acetamide

SMILES

CCOc(ccc(CC(Nc(c(N1CCCC1)c1)cc(N(C)C2=O)c1N(C)C2=O)=O)c1)c1OCC

InChI

InChI=1S/C26H32N4O5/c1-5-34-22-10-9-17(13-23(22)35-6-2)14-24(31)27-18-15-20-21(16-19(18)30-11-7-8-12-30)29(4)26(33)25(32)28(20)3/h9-10,13,15-16H,5-8,11-12,14H2,1-4H3,(H,27,31)

InChI Key

YAPTYKIOMXBBRX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27212026

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.174

Distribution Coefficient, logD

2.129

Water Solubility, LogSw

-3.02

Polar Surface Area

70.716

Acid Dissociation Constant (pKa)

8.36

Base Dissociation Constant (pKb)

2.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.30

G266-1325 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G266-1325 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G266-1325?
Check Price and Availability of G266-1325, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G266-1325 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G266-1325
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G266-1325
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G266-1325 available by request